G D Shapiro1, L Dodds2, T E Arbuckle3, J Ashley-Martin4, W Fraser5, M Fisher3, S Taback6, E Keely7, M F Bouchard8, P Monnier9, R Dallaire10, As Morisset8, A S Ettinger11. 1. Department of Social and Preventive Medicine, Université de Montréal, Montréal, Quebec, Canada; CHU Sainte-Justine Research Centre, Université de Montréal, Montréal, Quebec, Canada. 2. Dalhousie University, Halifax, Nova Scotia, Canada. Electronic address: L.Dodds@dal.ca. 3. Health Canada, Ottawa, Ontario, Canada. 4. Dalhousie University, Halifax, Nova Scotia, Canada. 5. CHU Sainte-Justine Research Centre, Université de Montréal, Montréal, Quebec, Canada; Department of Obstetrics and Gynecology, Université de Montréal, Montréal, Quebec, Canada. 6. University of Manitoba, Winnipeg, Manitoba, Canada. 7. University of Ottawa, Ottawa, Ontario, Canada. 8. CHU Sainte-Justine Research Centre, Université de Montréal, Montréal, Quebec, Canada. 9. McGill University, Montréal, Quebec, Canada. 10. Laval University, Québec City, Quebec, Canada. 11. Yale University, New Haven, CT, USA.
Abstract
BACKGROUND: Studies from several countries report increases in rates of gestational diabetes mellitus (GDM) over recent decades. Exposure to environmental chemicals could contribute to this trend. OBJECTIVES: To determine the associations between plasticisers and metals measured in early pregnancy with impaired glucose tolerance (IGT) and GDM in a Canadian pregnancy cohort. METHODS: Women enrolled in the Maternal-Infant Research on Environmental Chemicals (MIREC) Study were included if they had a singleton delivery and did not have pre-existing diabetes. Eleven phthalate metabolites and total bisphenol A (BPA) were measured in first-trimester urine samples, and four metals (lead, cadmium, mercury and arsenic) were measured in first-trimester blood samples. IGT and GDM were assessed in accordance with standard guidelines by chart review. Chemical concentrations were grouped by quartiles, and associations with outcomes were examined using logistic regression with adjustment for maternal age, race, pre-pregnancy BMI, and education. Restricted cubic spline analysis was performed to help assess linearity and nature of any dose-response relationships. RESULTS: Of 2001 women recruited into the MIREC cohort, 1274 met the inclusion criteria and had outcome data and biomonitoring data measured for at least one of the chemicals we examined. Elevated odds of GDM were observed in the highest quartile of arsenic exposure (OR = 3.7, 95% CI = 1.4-9.6) in the adjusted analyses. A significant dose-response relationship was observed in a cubic spline model between arsenic and odds of GDM (p < 0.01). No statistically significant associations were observed between phthalates or BPA or other metals with IGT or GDM. CONCLUSIONS: Our findings add to the growing body of evidence supporting the role of maternal arsenic exposure as a risk factor for gestational diabetes.
BACKGROUND: Studies from several countries report increases in rates of gestational diabetes mellitus (GDM) over recent decades. Exposure to environmental chemicals could contribute to this trend. OBJECTIVES: To determine the associations between plasticisers and metals measured in early pregnancy with impaired glucose tolerance (IGT) and GDM in a Canadian pregnancy cohort. METHODS:Women enrolled in the Maternal-Infant Research on Environmental Chemicals (MIREC) Study were included if they had a singleton delivery and did not have pre-existing diabetes. Eleven phthalate metabolites and total bisphenol A (BPA) were measured in first-trimester urine samples, and four metals (lead, cadmium, mercury and arsenic) were measured in first-trimester blood samples. IGT and GDM were assessed in accordance with standard guidelines by chart review. Chemical concentrations were grouped by quartiles, and associations with outcomes were examined using logistic regression with adjustment for maternal age, race, pre-pregnancy BMI, and education. Restricted cubic spline analysis was performed to help assess linearity and nature of any dose-response relationships. RESULTS: Of 2001 women recruited into the MIREC cohort, 1274 met the inclusion criteria and had outcome data and biomonitoring data measured for at least one of the chemicals we examined. Elevated odds of GDM were observed in the highest quartile of arsenic exposure (OR = 3.7, 95% CI = 1.4-9.6) in the adjusted analyses. A significant dose-response relationship was observed in a cubic spline model between arsenic and odds of GDM (p < 0.01). No statistically significant associations were observed between phthalates or BPA or other metals with IGT or GDM. CONCLUSIONS: Our findings add to the growing body of evidence supporting the role of maternal arsenic exposure as a risk factor for gestational diabetes.
Authors: Rachel M Shaffer; Kelly K Ferguson; Lianne Sheppard; Tamarra James-Todd; Samantha Butts; Suchitra Chandrasekaran; Shanna H Swan; Emily S Barrett; Ruby Nguyen; Nicole Bush; Thomas F McElrath; Sheela Sathyanarayana Journal: Environ Int Date: 2019-01-07 Impact factor: 9.621
Authors: Damaskini Valvi; Youssef Oulhote; Pal Weihe; Christine Dalgård; Kristian S Bjerve; Ulrike Steuerwald; Philippe Grandjean Journal: Environ Int Date: 2017-07-25 Impact factor: 9.621
Authors: Tamarra M James-Todd; John D Meeker; Tianyi Huang; Russ Hauser; Kelly K Ferguson; Janet W Rich-Edwards; Thomas F McElrath; Ellen W Seely Journal: Environ Int Date: 2016-09-17 Impact factor: 9.621
Authors: Balal Yousaf; Guijian Liu; Ruwei Wang; Abdul Qadir; Muhammad Ubaid Ali; Qudsia Kanwal; Bushra Munir; Zaigham Abbas Journal: Environ Sci Pollut Res Int Date: 2016-03-03 Impact factor: 4.223